Dm Disease-A-MonthPub Date : 2024-12-01DOI: 10.1016/j.disamonth.2024.101824
Michael Mallary PhD, FIEEE
{"title":"Lactose Intolerance – A practical approach, Part 2 An approach to foods","authors":"Michael Mallary PhD, FIEEE","doi":"10.1016/j.disamonth.2024.101824","DOIUrl":"10.1016/j.disamonth.2024.101824","url":null,"abstract":"","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":"70 12","pages":"Article 101824"},"PeriodicalIF":3.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dm Disease-A-MonthPub Date : 2024-12-01DOI: 10.1016/j.disamonth.2024.101823
RB McFee DO, MPH, FACPM, FAACT
{"title":"Lactose intolerance – A practical approach, Part 1","authors":"RB McFee DO, MPH, FACPM, FAACT","doi":"10.1016/j.disamonth.2024.101823","DOIUrl":"10.1016/j.disamonth.2024.101823","url":null,"abstract":"<div><div>The toxicology, immunology and gastroenterology aspects of food remain important in clinical practice, as anyone treating food related anaphylaxis, or chronic intolerance syndromes can attest. Although entire editions of journals could focus on any one aspect of adverse effects from food, the following review addresses the important and prevalent gastrointestinal condition lactose intolerance and gastrointestinal (GI) conditions that have similar presentation but require different treatment.</div></div>","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":"70 12","pages":"Article 101823"},"PeriodicalIF":3.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dm Disease-A-MonthPub Date : 2024-12-01DOI: 10.1016/j.disamonth.2024.101828
Robin B. McFee DO, MPH, FACPM, FAACT
{"title":"Gastrointestinal disorders – Clinical challenges for the primary care clinician","authors":"Robin B. McFee DO, MPH, FACPM, FAACT","doi":"10.1016/j.disamonth.2024.101828","DOIUrl":"10.1016/j.disamonth.2024.101828","url":null,"abstract":"<div><div>Gastrointestinal (GI) associated symptoms are among the most common medical concerns resulting in visits to primary and specialty care. Especially challenging is the wide range of causative disorders and exposures associated with symptoms ranging from mild to life threatening - from within the GI tract as well as extra-gastrointestinal. Some of these are well described, and common, including infections, while others are newly emerging, such as cannabinoid hyperemesis syndrome. Others are well known but clinical success can remain elusive, such as food associated GI disorders - lactose intolerance and related. Although entire references have been written to address gastrointestinal diseases, in this edition of Disease a Month we will address some of the more challenging GI disorders; some of which are common but often difficult to control - food associated for example, and emerging GI illnesses such as radiation or cannabinoid hyperemesis, that lead patients to the Emergency Department, primary care clinician or specialty referral. What follows is a discussion of diverse but clinically important GI disorders, and the newer therapeutic strategies to help patients better manage their symptoms, and improve their quality of life.</div></div>","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":"70 12","pages":"Article 101828"},"PeriodicalIF":3.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dm Disease-A-MonthPub Date : 2024-11-01DOI: 10.1016/j.disamonth.2024.101778
Sneha Annie Sebastian MD , Yash Shah MD , Camelia Arsene MD, PhD, MHS
{"title":"Intermittent fasting and cardiovascular disease: A scoping review of the evidence","authors":"Sneha Annie Sebastian MD , Yash Shah MD , Camelia Arsene MD, PhD, MHS","doi":"10.1016/j.disamonth.2024.101778","DOIUrl":"10.1016/j.disamonth.2024.101778","url":null,"abstract":"<div><div><span>Intermittent fasting (IF), characterized by alternating periods of fasting and unrestricted eating, typically within an 8-hour window or less each day, has gained significant attention as a possible dietary approach. While it is recognized for its metabolic advantages, like weight loss and enhanced glucose and </span>insulin sensitivity, its effect on cardiovascular health remains a topic of mixed opinions. Recent findings suggest a potential downside, with reports indicating a concerning association: a 91 % higher risk of cardiovascular disease (CVD) mortality compared to eating spread across a 12- to 16-hour period. Despite this alarming statistic, the evidence cannot establish a causal link. The impact of IF on CVD is still insufficiently understood, with benefits sometimes exaggerated and risks downplayed in popular discourse. This scoping review aims to consolidate the current evidence, addressing unresolved questions about the benefits and risks of IF, particularly its association with CVD risks and mortality. The goal is to provide a balanced perspective on the potential health implications of IF, emphasizing the need for further research to clarify its long-term effects on cardiovascular health.</div></div>","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":"70 11","pages":"Article 101778"},"PeriodicalIF":3.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Foreword for Intermittent Fasting and Cardiovascular Disease: A scoping review of the Evidence","authors":"Jerrold B. Leikin MD FACOEM, FACP, FACEP, FACMT, FAACT, FASAM (Senior EditorDisease-A-Month)","doi":"10.1016/j.disamonth.2024.101777","DOIUrl":"10.1016/j.disamonth.2024.101777","url":null,"abstract":"","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":"70 11","pages":"Article 101777"},"PeriodicalIF":3.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}